Home › Compugen Discloses Focused Target Discovery Program For Antibody-Drug Conjugate Cancer Therapy
 

Keywords :   


Compugen Discloses Focused Target Discovery Program For Antibody-Drug Conjugate Cancer Therapy

2013-04-02 09:55:00| drugdiscoveryonline News Articles

Compugen Ltd. disclosed recently the initiation of its second focused discovery program, aimed at identification of novel targets for antibody-drug conjugate (ADC) cancer therapy focusing on clinical situations with poor survival rates and/or recurrent cancers

Tags: program target cancer focused

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Reeves: 'There's not a huge amount of money'
05.07Rachel Reeves: Who is the UK's new chancellor?
05.07US jobs growth in June beats expectations
05.07Covestro, Abu Dhabi National Oil Company Enter into Negotiations
05.07BCF Helps Transform More Than 800 Disused Phone Boxes
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Public Advisory Number 27A
05.07Atlantic Tropical Weather Outlook
More »